PUBLIC COMPANY
saveLaNova Medicines Ltd
updated 2mo ago
community read0 votes
pipeline
2
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(2)
pipeline depth2 products
2Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase3LM-108 in Combination With Toripalimab Versus Paclitaxel Injection for the Treatment of Subjects With CCR8-Positive Gastric and Gastroesophageal Junction Adenocarcinoma
- phase2Phase II Study of LM-24C5
- phase2A Study of LM-108 as Monotherapy or in Combination With Antitumor Therapies in Subjects With Advanced Solid Tumors
- phase2A Study of LM-350 in Subjects With Advanced Solid Tumours
- phase2A Phase I/II Study of LM-2417 in Subjects With Advanced Solid Tumours
- phase2A Study of LM-168 as a Single Agent or in Combination With Toripalimab in Subjects With Advanced Solid Tumours
- phase2A Study of LM-24C5 For Advanced Solid Tumors
- phase2Study of LM-299 in Subjects Advanced Malignant Tumors
🐶 Hiring Signal
News
- Merck posts—then pulls—trial plan for PD-1xVEGF and TROP2 ADC combinationAfter keeping tight-lipped for nearly two years, Merck & Co. briefly dropped the first concrete hint as to where it intends to take its PD-1xVEGF bispecific antibody—before quietly scrubbing the ev…fiercebiotech · 22d ago
comments(0)
5-min edit window · permanent after that